Paris (France), Copenhagen (Denmark) – Onxeo S.A. (Euronext Paris, Nasdaq Copenhagen: ONXEO), a biopharmaceutical company specializing in the development of innovative drugs for the treatment of orphan diseases, in particular in oncology, today announced its financial calendar for 2017:
March 7, 2017 Full-year 2016 consolidated accounts
April 26, 2017 General shareholders’ meeting (to be convened in Paris)
April 27, 2017 Quarterly information as of March 31, 2017
July 28, 2017 Consolidated accounts for the 1st half of 2017
October 26, 2017 Quarterly information as of September 30, 2017
This financial calendar is for indicative purposes only and Onxeo could change its publication dates should it deem it necessary.